108 related articles for article (PubMed ID: 2302059)
1. Tumor-associated antigen immune complexes. A potential marker of recurrent melanoma.
Wong JH; Xu SH; Gupta RK; Morton DL
Arch Surg; 1990 Feb; 125(2):187-91. PubMed ID: 2302059
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of the use of antigen-specific immune complexes in predicting the development of recurrent melanoma.
Wong JH; Xu SH; Skinner KA; Foshag LJ; Morton DL
Arch Surg; 1991 Dec; 126(12):1450-4. PubMed ID: 1842173
[TBL] [Abstract][Full Text] [Related]
3. Detection and isolation of antigen-specific immune complexes from sera of melanoma patients.
Wong JH; Xu SH; Saxton RE; Gupta RK; Morton DL
Int J Cancer; 1990 Mar; 45(3):445-9. PubMed ID: 1689702
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
Morgan AC; McIntyre RF
Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody-based ELISA to detect glycoprotein tumor-associated-antigen-specific immune complexes in cancer patients.
Gupta RK; Morton DL
J Clin Lab Anal; 1992; 6(5):329-36. PubMed ID: 1403355
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma.
Kelley MC; Jones RC; Gupta RK; Yee R; Stern S; Wanek L; Morton DL
Cancer; 1998 Oct; 83(7):1355-61. PubMed ID: 9762936
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a 90kD subunit containing glycoprotein tumor-associated antigen specific immune complexes in lung cancer patients.
Gupta RK; Morton DL
Dis Markers; 1994 Oct; 12(1):51-61. PubMed ID: 7842631
[TBL] [Abstract][Full Text] [Related]
8. Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients.
Wong JH; Aguero B; Gupta RK; Morton DL
Cancer Immunol Immunother; 1988; 27(2):142-6. PubMed ID: 3046746
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical characterization of a tumor-associated antigen defined by a monoclonal antibody.
Wong JH; Xu SH; Saxton RE; Gupta RK; Morton DL
J Surg Res; 1990 Jun; 48(6):539-46. PubMed ID: 2194070
[TBL] [Abstract][Full Text] [Related]
10. Detection of a tumor-associated glycoprotein antigen in serum and urine of melanoma patients by murine monoclonal antibody (AD1-40F4) in enzyme immunoassay.
Euhus DM; Gupta RK; Morton DL
J Clin Lab Anal; 1989; 3(3):184-90. PubMed ID: 2754533
[TBL] [Abstract][Full Text] [Related]
11. Circulating melanoma-associated antigens in ocular melanoma.
Whitmore WG; Witkin SS; Ellsworth RM
Ann Ophthalmol; 1988 Jun; 20(6):212-7. PubMed ID: 3408088
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of urinary antigen analysis by enzyme-linked immunosorbent assay in melanoma patients.
Gupta RK; Huth JF; Korn EL; Morton DL
Diagn Immunol; 1983; 1(4):303-9. PubMed ID: 6388975
[TBL] [Abstract][Full Text] [Related]
13. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.
Wong JH; Gupta RK; Morton DL
Arch Surg; 1986 Nov; 121(11):1342-5. PubMed ID: 3778209
[TBL] [Abstract][Full Text] [Related]
14. Detection of epithelial ovarian-cancer-associated antigens involved in immune complexes by monoclonal antibodies.
Kawata M; Sekiya S
Tumour Biol; 1998; 19(1):1-11. PubMed ID: 9422077
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and nature of circulating immune complexes in melanoma patients.
Gupta RK; Morton DL
Contemp Top Immunobiol; 1985; 15():1-53. PubMed ID: 3896641
[No Abstract] [Full Text] [Related]
16. Measurement of a monoclonal antibody-defined, melanoma-associated antigen in human sera: correlation of circulating antigen levels with tumor burden.
Morgan AC; Crane MM; Rossen RD
J Natl Cancer Inst; 1984 Feb; 72(2):243-9. PubMed ID: 6582312
[TBL] [Abstract][Full Text] [Related]
17. Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.
Ross AH; Herlyn M; Ernst CS; Guerry D; Bennicelli J; Ghrist BF; Atkinson B; Koprowski H
Cancer Res; 1984 Oct; 44(10):4642-7. PubMed ID: 6380710
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated antigens recognized by human monoclonal antibodies.
Chang HR; Koda K; McKnight ME; Glassy MC
Ann Surg Oncol; 1994 May; 1(3):213-21. PubMed ID: 7842291
[TBL] [Abstract][Full Text] [Related]
19. Immune complexes in human melanoma: a consequence of deranged immune regulation.
Jerry LM; Rowden G; Cano PO; Phillips TM; Deutsch GF; Capek A; Hartmann D; Lewis MG
Scand J Immunol; 1976; 5(6-7):845-59. PubMed ID: 981971
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of immune complexes, associated antigen, and antibody in cancer.
Salinas FA; Wee KH; Silver HK
Contemp Top Immunobiol; 1985; 15():55-109. PubMed ID: 3896644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
